NCT04933591View on ClinicalTrials.gov

Impact of Treatment With VENARUS® on the Level of Monocyte Chemoattractant Protein 1 in Varicose Veins Blood

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

August 28, 2021

Study Completion Date

September 28, 2021

Conditions
Varicose Veins
Interventions
DRUG

Diosmin / Hesperidin

Venoactive drugs are used for patients with varicose veins as a tool for alleviating symptoms

Trial Locations (1)

117997

Pirogov Russian National Research Medical University, Moscow

All Listed Sponsors
lead

Pirogov Russian National Research Medical University

OTHER

NCT04933591 - Impact of Treatment With VENARUS® on the Level of Monocyte Chemoattractant Protein 1 in Varicose Veins Blood | Biotech Hunter | Biotech Hunter